Delivery Order SPE2DB24D2205-SPE2DB25FDXNL
Award Date
1/29/25
Potential Completion Date
1/30/25
Potential Value
$62K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $41,267.12, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. This is a firm fixed-price delivery order contract with an ultimate completion date of April 22, 2024. The contract does not have a set-aside designation....
This federal contract award is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,443.52 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 5, 2024. The contract has an ultimate completion date of December 6, 2024 and is not designated as a set-aside. Amerisourcebergen maintains a $999,999,999...
The federal contract award is for the pharmaceutical product ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, with a ceiling value of $35,698.20. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order contract with a Firm Fixed Price pricing type, awarded by the Defense Logistics Agency (DLA), an agency within the Department of Defense. The contract does not have a set-aside...
This federal contract award is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $17,695.04, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen), as a firm fixed-price delivery order. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to...
This federal contract award, valued at $1,426.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication, with a completion date of December 4, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML pharmaceutical products. The $1,973.16 contract has a completion date of January 29, 2024 and was awarded on January 26, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication. The contract has a ceiling value of $13,213.09 and was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 23, 2024. The contract is not designated with a...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $3,666.64 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA for the provision of pharmaceutical products and medical supplies to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,649.47 firm-fixed-price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication. The contract has an ultimate completion date of October 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML pharmaceutical products. The delivery order, valued at $5,292.75, has an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) awarded by DLA, with a potential value of $999,999,999.00...